Back

DIGITAL-AF II: Smartphone-based atrial fibrillation screening in the general population

2 September 2019 (11:00 - 11:18)
Organised by:
Congress Presentation Part of: Advances in digital health Remote Patient Monitoring and Telehealth, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo
Miss Tine Proesmans

Hasselt University, Hasselt (Belgium)

4 More presentations in this session

Presentation thumbnail
Hybrid telerehabilitation and telecare vs usual care in heart failure patients-result of the first randomized,prospective,open-label,parallel group,controlled,multi-center-TELEREH-HF study
Professor E. Piotrowicz (Warsaw, PL)
Video
Presentation thumbnail
Mobile Health (mHealth) technology for improved optimization of integrated care in patients with atrial fibrillation: a 6 month interim report from the mAFA-II trial
Professor Y. Guo (Beijing, CN)
Slides Video
Presentation thumbnail
HERMES Study: Using Cardiolinguistics and Artificial Intelligence to Reframe Typical and Atypical Angina
Doctor C. Kreatsoulas (Boston, US)
Slides Video
Presentation thumbnail
Motivational Interviewing and mHealth for Community Health Workers to Improve Hypertension Management in Western Kenya: Results of the LARK Hypertension Study
Doctor R. Vedanthan (New York, US)
Slides Video

Access the full session

Session thumbnail
Advances in digital health

The Event

Event poster

ESC Congress 2019

2 September 2019 11:00 CET
You may be interested in
thumbnail
Webinar
The acceleration in digital healthcare: challenges and barriers
18 January 2022
thumbnail
Congress Presentation
CardioSignal: a novel smartphone-based mechanocardiography tool for detection of atrial fibrillation recurrence after catheter ablation
12 April 2026
thumbnail
Congress Presentation
European survey on general practitioners' perceptions on opportunistic single time point screening for atrial fibrillation
4 April 2022
thumbnail
Congress Presentation
Impact of CHA2DS2-VASc score on smartphone-based screening for atrial fibrillation: A pre-specified subgroup analysis of the eBRAVE-AF trial
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources